Literature DB >> 36262267

Effectivity and efficacy probiotics for Bacterial Vaginosis treatments: Meta-analysis.

Sri Adila Nurainiwati1, Mochammad Ma'roef2, Dwi Nurwulan Pravitasari1, Probo Yudha Pratama Putra3.   

Abstract

Introduction: Bacterial Vaginosis (BV) is the most common cause of vaginal discharge. However, in some cases, side effects and resistance rates have been reported when antibiotics are administered. This problem has prompted several investigations on the administration of probiotics as an adjunct therapy to treat this infection. Objection: This study aims to conduct a meta-analysis based on evidence to determine the efficacy and safety of probiotic and antibiotic treatments.
Methods: The meta-analysis was performed using PRISMA guidelines. The literature review was conducted in December 2020 using PubMed, Science Direct, Cochrane Library, and RevMan V.5.3. Result: The results showed a high and significant cure rate from the analysis of 1006 and 528 samples of probiotics and non-probiotics or control in 16 studies. The recurrence rate was statistically significant with probiotic treatment. Furthermore, neither procedures nor therapy failure showed a significantly lower adverse event rate than the control group.
Conclusion: Probiotic shows better results compared to the control group. However, both have the same occurrence of adverse event.
© 2022 The Authors.

Entities:  

Keywords:  Antibiotics; BV, Bacterial Vaginosis; Bacterial Vaginosis; CDC, Centers for Disease Control; CRISPR, Clustered regularly interspaced short palindromic repeat-associated; Probiotics; RCTs, Randomized Control Trials

Year:  2022        PMID: 36262267      PMCID: PMC9576480          DOI: 10.1016/j.idm.2022.09.001

Source DB:  PubMed          Journal:  Infect Dis Model        ISSN: 2468-0427


  40 in total

1.  Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.

Authors:  Julie van Schalkwyk; Mark H Yudin
Journal:  J Obstet Gynaecol Can       Date:  2015-03

2.  Therapeutic effects of probiotic Clostridium butyricum WZ001 on bacterial vaginosis in mice.

Authors:  Y Zhou; W Xu; K Hong; H Li; J Zhang; X Chen; Y Zhu; Q Zhang; F Ding; F Wang
Journal:  J Appl Microbiol       Date:  2019-06-07       Impact factor: 3.772

Review 3.  Characterization and Treatment of Recurrent Bacterial Vaginosis.

Authors:  Brooke M Faught; Sonia Reyes
Journal:  J Womens Health (Larchmt)       Date:  2019-08-12       Impact factor: 2.681

4.  Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.

Authors:  Paul Nyirjesy; Jane R Schwebke
Journal:  Future Microbiol       Date:  2018-01-12       Impact factor: 3.165

5.  Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.

Authors:  Ruben Hummelen; John Changalucha; Nicodemus L Butamanya; Adrian Cook; J Dik F Habbema; Gregor Reid
Journal:  Int J Gynaecol Obstet       Date:  2010-12       Impact factor: 3.561

Review 6.  Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis.

Authors:  Yue Han; Qing-Ling Ren
Journal:  Curr Opin Pharmacol       Date:  2021-10-11       Impact factor: 5.547

7.  Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial.

Authors:  Rafael C R Martinez; Sílvio A Franceschini; Maristela C Patta; Silvana M Quintana; Bruna C Gomes; Elaine C P De Martinis; Gregor Reid
Journal:  Can J Microbiol       Date:  2009-02       Impact factor: 2.419

Review 8.  Effects of probiotics on the recurrence of bacterial vaginosis: a review.

Authors:  Aziz Homayouni; Parvin Bastani; Somayeh Ziyadi; Sakineh Mohammad-Alizadeh-Charandabi; Morad Ghalibaf; Amir Mohammad Mortazavian; Elnaz Vaghef Mehrabany
Journal:  J Low Genit Tract Dis       Date:  2014-01       Impact factor: 1.925

9.  Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses.

Authors:  Per-Göran Larsson; Erik Brandsborg; Urban Forsum; Sonal Pendharkar; Kasper Krogh Andersen; Salmir Nasic; Lennart Hammarström; Harold Marcotte
Journal:  BMC Infect Dis       Date:  2011-08-19       Impact factor: 3.090

10.  Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.

Authors:  Marijn C Verwijs; Stephen K Agaba; Alistair C Darby; Janneke H H M van de Wijgert
Journal:  Am J Obstet Gynecol       Date:  2019-08-09       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.